Vir Biotechnology (VIR) director awarded 8,000 RSUs and 16,000-share stock option
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Vir Biotechnology director Ramy Farid reported routine equity compensation awards. He received 8,000 shares of Common Stock as restricted stock units under the company’s equity incentive plan, bringing his direct holdings to 32,000 shares after the grant.
He was also granted a stock option for 16,000 shares of Common Stock at an exercise price of $9.10 per share. Both the RSUs and the option are scheduled to vest in full on May 27, 2027, and the option expires on May 26, 2036. These are compensation-related acquisitions, not open-market purchases.
Positive
- None.
Negative
- None.
Insights
Routine director equity awards with time-based vesting.
Vir Biotechnology granted director Ramy Farid 8,000 RSUs and an option for 16,000 shares at $9.10, all vesting in full on May 27, 2027. These are standard board compensation tools, not market transactions.
The filing shows Farid now directly holds 32,000 common shares plus this new option position. Because these awards are part of an equity incentive plan and not open-market buying or selling, they carry limited signaling value for the company’s short-term outlook.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
Farid Ramy
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 16,000 | $0.00 | -- |
| Grant/Award | Common Stock | 8,000 | $0.00 | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 16,000 shares (Direct, null);
Common Stock — 32,000 shares (Direct, null)
Footnotes (1)
- Acquisition of restricted stock units (RSUs) pursuant to the Issuer's Equity Incentive Plan. The RSUs will vest in full on May 27, 2027. The shares subject to the stock option will vest and become exercisable in full on May 27, 2027.
Key Figures
RSU grant size: 8,000 shares
Shares held after RSU grant: 32,000 shares
Option grant size: 16,000 shares
+3 more
6 metrics
RSU grant size
8,000 shares
Restricted stock units granted on May 27, 2026
Shares held after RSU grant
32,000 shares
Common Stock directly held after acquisition
Option grant size
16,000 shares
Stock option covering Common Stock
Option exercise price
$9.10/share
Exercise price for 16,000-share stock option
Vesting date
May 27, 2027
Full vesting for RSUs and stock option
Option expiration
May 26, 2036
Expiration date of stock option grant
Key Terms
restricted stock units (RSUs), Equity Incentive Plan, stock option, Common Stock
4 terms
restricted stock units (RSUs) financial
"Acquisition of restricted stock units (RSUs) pursuant to the Issuer's Equity Incentive Plan."
Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.
Equity Incentive Plan financial
"Acquisition of restricted stock units (RSUs) pursuant to the Issuer's Equity Incentive Plan."
An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.
stock option financial
"The shares subject to the stock option will vest and become exercisable in full on May 27, 2027."
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
Common Stock financial
"Stock Option (Right to Buy) ... underlying security title: Common Stock"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
FAQ
What did Vir Biotechnology (VIR) director Ramy Farid receive in this Form 4?
Ramy Farid received 8,000 shares of Vir Biotechnology Common Stock as restricted stock units and a stock option for 16,000 shares. Both awards were granted as part of the company’s equity incentive plan, reflecting routine director compensation rather than open-market trading.
At what price can the new Vir Biotechnology (VIR) stock options be exercised?
The newly granted Vir Biotechnology stock options have an exercise price of $9.10 per share. They cover 16,000 shares of Common Stock and were awarded as part of an equity incentive plan, with vesting and exercisability scheduled together on a future date.
When do Ramy Farid’s new Vir Biotechnology (VIR) RSUs and options vest?
Both the 8,000 restricted stock units and the 16,000-share stock option granted to Ramy Farid vest in full on May 27, 2027. At that time, the RSUs convert to shares and the option becomes fully exercisable, subject to the plan’s usual conditions.
Is this Vir Biotechnology (VIR) Form 4 a market purchase or routine award?
This Form 4 reflects routine equity compensation awards, not a market purchase or sale. Farid received 8,000 RSUs and a 16,000-share stock option under Vir Biotechnology’s equity incentive plan, both vesting in 2027, with no cash-paid open-market transaction reported.